DOI . ORG {}

Matching Content Categories {📚}

• Health & Fitness
• Education
• Science

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We don’t know how the website earns money.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Doi.org has a secret sauce for making money, but we can't detect it yet.

Keywords {🔍}

cancer, breast, article, google, scholar, cas, advanced, oncol, hormone, therapy, endocrine, metastatic, palbociclib, receptorpositive, metaanalysis, treatment, phase, cdk, inhibitors, carlo, receptor, clin, letrozole, harbeck, fulvestrant, systematic, review, randomized, messina, trial, patients, res, study, paloma, women, analysis, data, trials, hrher, clinical, pubmed, access, human, rugo, hernegative, iwata, ann, privacy, cookies, content,

Topics {✒️}

anti-cancer therapies patient-reported health-related quality hr+/her2− breast cancer metastatic breast cancer advanced breast cancer month download article/chapter hormone receptor-positive hormone-receptor-positive prior endocrine therapy-safety breast cancer statistics breast cancer markers de la cruz-merino randomized clinical trials oestrogen receptor-positive endocrine resistance �� g3–g4 adverse events her2-negative related subjects targeted agents full article pdf cyclin-dependent kinase 4 privacy choices/manage cookies objective response rates breast cancer phase iii trial phase iii study cyclin-dependent kinases patient-reported outcomes author information authors versus endocrine therapy previous endocrine therapy receiving endocrine therapy randomized trials g3–g4 neutropenia check access instant access clinical trials carlo cattrini finn rs systematic literature search initial endocrine therapy cost-utility analysis endocrine-resistant population endocrine-resistant setting van kampen rj van den berkmortel initial palliative therapy conditions privacy policy adding cdk4/6 inhibitors random-effects model

Schema {🗺️}

WebPage:
      mainEntity:
         headline:CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials
         description:Combining CDK4/6 inhibitors and endocrine therapy (ET) improved outcomes for the treatment of metastatic HR+/HER2− breast cancers. Here, we performed a meta-analysis of randomized clinical trials (RCTs) to better define the benefit and the risk of CDK4/6 inhibitors plus ET for endocrine-sensitive or endocrine-resistant population in metastatic HR+/HER2− breast cancer. A systematic literature search of Pubmed, Embase, and the Cochrane Library was carried out up to 30 June 2018. Hazard ratios (HRs) and 95% confidence intervals (CIs) for progression-free survival (PFS), as well as odds ratios (ORs) for objective response rates, ≥ G3–G4 adverse events (AEs), and G3–G4 neutropenia were calculated for each trial. A meta-analysis was carried out using the random-effects model. Eight RCTs were eligible including 4578 breast cancer patients. Adding CDK4/6 inhibitors to ET in endocrine-sensitive (HR 0.55, 95% CI 0.50–0.62) or endocrine-resistant setting (HR 0.51, 95% CI 0.43–0.61) significantly improved the PFS of metastatic HR+/HER2− breast cancers regardless of menopausal status and site of metastasis. Moreover, CDK4/6 inhibitors plus ET meaningfully improved objective response rate in endocrine-sensitive (ORs 0.62, 95% CI 0.52–0.73) or endocrine-resistant setting (ORs 0.33, 95% CI 0.24–0.47). The use of these drugs was characterized by a significant increase of G3–G4 AEs (OR 10.88, 95% CI 6.53–18.14). Emerging data provide a new standard treatment for advanced HR+/HER2− breast cancer, regardless of menopausal status, prior hormonal/chemotherapy treatments delivered, sites of metastasis. However, benefits should be balanced with longer treatment duration, toxicities, and costs.
         datePublished:2018-07-27T00:00:00Z
         dateModified:2018-07-27T00:00:00Z
         pageStart:9
         pageEnd:21
         sameAs:https://doi.org/10.1007/s10549-018-4901-0
         keywords:
            Abemaciclib
            Ribociclib
            Palbociclib
            Hormonal therapy
            Breast cancer
            Meta-analysis
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4901-0/MediaObjects/10549_2018_4901_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4901-0/MediaObjects/10549_2018_4901_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4901-0/MediaObjects/10549_2018_4901_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4901-0/MediaObjects/10549_2018_4901_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4901-0/MediaObjects/10549_2018_4901_Fig5_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4901-0/MediaObjects/10549_2018_4901_Fig6_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:172
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Carlo Messina
               url:http://orcid.org/0000-0002-7934-1419
               affiliation:
                     name:Policlinico Hospital San Martino-IST
                     address:
                        name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
                        type:PostalAddress
                     type:Organization
                     name:University of Genoa
                     address:
                        name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Carlo Cattrini
               affiliation:
                     name:Policlinico Hospital San Martino-IST
                     address:
                        name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
                        type:PostalAddress
                     type:Organization
                     name:University of Genoa
                     address:
                        name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Giulia Buzzatti
               affiliation:
                     name:Policlinico Hospital San Martino-IST
                     address:
                        name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
                        type:PostalAddress
                     type:Organization
                     name:University of Genoa
                     address:
                        name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Luigi Cerbone
               affiliation:
                     name:Policlinico Hospital San Martino-IST
                     address:
                        name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
                        type:PostalAddress
                     type:Organization
                     name:University of Genoa
                     address:
                        name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Elisa Zanardi
               affiliation:
                     name:Policlinico Hospital San Martino-IST
                     address:
                        name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
                        type:PostalAddress
                     type:Organization
                     name:University of Genoa
                     address:
                        name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marco Messina
               affiliation:
                     name:Istituto Fondazione G. Giglio
                     address:
                        name:Oncology Unit, Istituto Fondazione G. Giglio, Cefalù, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Francesco Boccardo
               affiliation:
                     name:Policlinico Hospital San Martino-IST
                     address:
                        name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
                        type:PostalAddress
                     type:Organization
                     name:University of Genoa
                     address:
                        name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials
      description:Combining CDK4/6 inhibitors and endocrine therapy (ET) improved outcomes for the treatment of metastatic HR+/HER2− breast cancers. Here, we performed a meta-analysis of randomized clinical trials (RCTs) to better define the benefit and the risk of CDK4/6 inhibitors plus ET for endocrine-sensitive or endocrine-resistant population in metastatic HR+/HER2− breast cancer. A systematic literature search of Pubmed, Embase, and the Cochrane Library was carried out up to 30 June 2018. Hazard ratios (HRs) and 95% confidence intervals (CIs) for progression-free survival (PFS), as well as odds ratios (ORs) for objective response rates, ≥ G3–G4 adverse events (AEs), and G3–G4 neutropenia were calculated for each trial. A meta-analysis was carried out using the random-effects model. Eight RCTs were eligible including 4578 breast cancer patients. Adding CDK4/6 inhibitors to ET in endocrine-sensitive (HR 0.55, 95% CI 0.50–0.62) or endocrine-resistant setting (HR 0.51, 95% CI 0.43–0.61) significantly improved the PFS of metastatic HR+/HER2− breast cancers regardless of menopausal status and site of metastasis. Moreover, CDK4/6 inhibitors plus ET meaningfully improved objective response rate in endocrine-sensitive (ORs 0.62, 95% CI 0.52–0.73) or endocrine-resistant setting (ORs 0.33, 95% CI 0.24–0.47). The use of these drugs was characterized by a significant increase of G3–G4 AEs (OR 10.88, 95% CI 6.53–18.14). Emerging data provide a new standard treatment for advanced HR+/HER2− breast cancer, regardless of menopausal status, prior hormonal/chemotherapy treatments delivered, sites of metastasis. However, benefits should be balanced with longer treatment duration, toxicities, and costs.
      datePublished:2018-07-27T00:00:00Z
      dateModified:2018-07-27T00:00:00Z
      pageStart:9
      pageEnd:21
      sameAs:https://doi.org/10.1007/s10549-018-4901-0
      keywords:
         Abemaciclib
         Ribociclib
         Palbociclib
         Hormonal therapy
         Breast cancer
         Meta-analysis
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4901-0/MediaObjects/10549_2018_4901_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4901-0/MediaObjects/10549_2018_4901_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4901-0/MediaObjects/10549_2018_4901_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4901-0/MediaObjects/10549_2018_4901_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4901-0/MediaObjects/10549_2018_4901_Fig5_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-018-4901-0/MediaObjects/10549_2018_4901_Fig6_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:172
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Carlo Messina
            url:http://orcid.org/0000-0002-7934-1419
            affiliation:
                  name:Policlinico Hospital San Martino-IST
                  address:
                     name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
                     type:PostalAddress
                  type:Organization
                  name:University of Genoa
                  address:
                     name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Carlo Cattrini
            affiliation:
                  name:Policlinico Hospital San Martino-IST
                  address:
                     name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
                     type:PostalAddress
                  type:Organization
                  name:University of Genoa
                  address:
                     name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Giulia Buzzatti
            affiliation:
                  name:Policlinico Hospital San Martino-IST
                  address:
                     name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
                     type:PostalAddress
                  type:Organization
                  name:University of Genoa
                  address:
                     name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Luigi Cerbone
            affiliation:
                  name:Policlinico Hospital San Martino-IST
                  address:
                     name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
                     type:PostalAddress
                  type:Organization
                  name:University of Genoa
                  address:
                     name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Elisa Zanardi
            affiliation:
                  name:Policlinico Hospital San Martino-IST
                  address:
                     name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
                     type:PostalAddress
                  type:Organization
                  name:University of Genoa
                  address:
                     name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marco Messina
            affiliation:
                  name:Istituto Fondazione G. Giglio
                  address:
                     name:Oncology Unit, Istituto Fondazione G. Giglio, Cefalù, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Francesco Boccardo
            affiliation:
                  name:Policlinico Hospital San Martino-IST
                  address:
                     name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
                     type:PostalAddress
                  type:Organization
                  name:University of Genoa
                  address:
                     name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:172
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Policlinico Hospital San Martino-IST
      address:
         name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
         type:PostalAddress
      name:University of Genoa
      address:
         name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
         type:PostalAddress
      name:Policlinico Hospital San Martino-IST
      address:
         name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
         type:PostalAddress
      name:University of Genoa
      address:
         name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
         type:PostalAddress
      name:Policlinico Hospital San Martino-IST
      address:
         name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
         type:PostalAddress
      name:University of Genoa
      address:
         name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
         type:PostalAddress
      name:Policlinico Hospital San Martino-IST
      address:
         name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
         type:PostalAddress
      name:University of Genoa
      address:
         name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
         type:PostalAddress
      name:Policlinico Hospital San Martino-IST
      address:
         name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
         type:PostalAddress
      name:University of Genoa
      address:
         name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
         type:PostalAddress
      name:Istituto Fondazione G. Giglio
      address:
         name:Oncology Unit, Istituto Fondazione G. Giglio, Cefalù, Italy
         type:PostalAddress
      name:Policlinico Hospital San Martino-IST
      address:
         name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
         type:PostalAddress
      name:University of Genoa
      address:
         name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Carlo Messina
      url:http://orcid.org/0000-0002-7934-1419
      affiliation:
            name:Policlinico Hospital San Martino-IST
            address:
               name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
               type:PostalAddress
            type:Organization
            name:University of Genoa
            address:
               name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Carlo Cattrini
      affiliation:
            name:Policlinico Hospital San Martino-IST
            address:
               name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
               type:PostalAddress
            type:Organization
            name:University of Genoa
            address:
               name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
               type:PostalAddress
            type:Organization
      name:Giulia Buzzatti
      affiliation:
            name:Policlinico Hospital San Martino-IST
            address:
               name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
               type:PostalAddress
            type:Organization
            name:University of Genoa
            address:
               name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
               type:PostalAddress
            type:Organization
      name:Luigi Cerbone
      affiliation:
            name:Policlinico Hospital San Martino-IST
            address:
               name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
               type:PostalAddress
            type:Organization
            name:University of Genoa
            address:
               name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
               type:PostalAddress
            type:Organization
      name:Elisa Zanardi
      affiliation:
            name:Policlinico Hospital San Martino-IST
            address:
               name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
               type:PostalAddress
            type:Organization
            name:University of Genoa
            address:
               name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
               type:PostalAddress
            type:Organization
      name:Marco Messina
      affiliation:
            name:Istituto Fondazione G. Giglio
            address:
               name:Oncology Unit, Istituto Fondazione G. Giglio, Cefalù, Italy
               type:PostalAddress
            type:Organization
      name:Francesco Boccardo
      affiliation:
            name:Policlinico Hospital San Martino-IST
            address:
               name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
               type:PostalAddress
            type:Organization
            name:University of Genoa
            address:
               name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
      name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
      name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
      name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
      name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
      name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
      name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
      name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
      name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
      name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
      name:Oncology Unit, Istituto Fondazione G. Giglio, Cefalù, Italy
      name:Academic Unit of Medical Oncology, Policlinico Hospital San Martino-IST, Genoa, Italy
      name:Department of Internal Medicine, School of Medicine, University of Genoa, Genoa, Italy
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(157)

• See how much https://link.springer.com/privacystatement makes per month
• How much does https://link.springer.com/article/10.1007/s10549-018-4901-0/#main rake in every month?
• Get to know https://link.springer.com's earnings
• How much profit does https://idp.springer.com/auth/personal/springernature?redirect_uri=https://link.springer.com/article/10.1007/s10549-018-4901-0 make?
• https://link.springer.com/article/10.1007/s10549-018-4901-0/#eds-c-header-nav income
• https://link.springer.com/journals/'s revenue stream
• What is the earnings of https://www.springernature.com/gp/authors?
• Revenue of https://link.springernature.com/home/
• How much profit does https://link.springer.com/article/10.1007/s10549-018-4901-0/#eds-c-header-popup-search generate?
• How much does https://order.springer.com/public/cart net monthly?
• Income figures for https://link.springer.com/article/10.1007/s10549-018-4901-0/
• How much revenue does https://link.springer.com/article/10.1007/s10549-018-4901-0/journal/10549 generate?
• How much revenue does https://link.springer.com/article/10.1007/s10549-018-4901-0/#citeas produce monthly?
• How much does https://link.springer.com/article/10.1007/s10549-018-4901-0/journal/10549/aims-and-scope earn?
• How much does https://submission.springernature.com/new-submission/10549/3 pull in?
• How much does https://link.springer.com/article/10.1007/s10549-018-4901-0/#auth-Carlo-Messina-Aff1-Aff2 bring in each month?
• How profitable is https://orcid.org/0000-0002-7934-1419?
• Explore the financials of https://link.springer.com/article/10.1007/s10549-018-4901-0/#Aff1
• See how much https://link.springer.com/article/10.1007/s10549-018-4901-0/#Aff2 makes per month
• What are the earnings of https://link.springer.com/article/10.1007/s10549-018-4901-0/#auth-Carlo-Cattrini-Aff1-Aff2?
• How much money does https://link.springer.com/article/10.1007/s10549-018-4901-0/#auth-Giulia-Buzzatti-Aff1-Aff2 make?
• Learn how profitable https://link.springer.com/article/10.1007/s10549-018-4901-0/#auth-Luigi-Cerbone-Aff1-Aff2 is on a monthly basis
• How much does https://link.springer.com/article/10.1007/s10549-018-4901-0/#auth-Elisa-Zanardi-Aff1-Aff2 generate monthly?
• Discover the revenue of https://link.springer.com/article/10.1007/s10549-018-4901-0/#auth-Marco-Messina-Aff3
• How much revenue does https://link.springer.com/article/10.1007/s10549-018-4901-0/#Aff3 bring in?
• https://link.springer.com/article/10.1007/s10549-018-4901-0/#auth-Francesco-Boccardo-Aff1-Aff2 income
• Discover the revenue of https://link.springer.com/article/10.1007/s10549-018-4901-0/article/10.1007/s10549-018-4901-0/metrics
• Profit of https://wayf.springernature.com?redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs10549-018-4901-0
• How much does https://link.springer.com/product/springer-plus generate monthly?
• How much revenue does https://www.springernature.com/gp/librarians/licensing/agc/journals generate?
• Get to know https://link.springer.com/10.1007/s10549-020-05528-2?fromPaywallRec=true's earnings
• What are the earnings of https://link.springer.com/10.1186/s12905-025-03610-9?fromPaywallRec=true?
• https://link.springer.com/10.1007/s00432-023-05516-1?fromPaywallRec=true income
• Revenue of https://link.springer.com/article/10.1007/s10549-018-4901-0/subjects/cancer-therapeutic-resistance
• Get to know https://link.springer.com/article/10.1007/s10549-018-4901-0/subjects/endocrine-cancer's earnings
• How much profit does https://link.springer.com/article/10.1007/s10549-018-4901-0/subjects/hormonal-therapies generate?
• How much money does https://link.springer.com/article/10.1007/s10549-018-4901-0/subjects/neuroendocrine-cancer make?
• What are the total earnings of https://link.springer.com/article/10.1007/s10549-018-4901-0/subjects/phase-iv-trials?
• How much cash flow does https://link.springer.com/article/10.1007/s10549-018-4901-0/subjects/targeted-therapies have monthly?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Breast%20cancer%20statistics%2C%202017%2C%20racial%20disparity%20in%20mortality%20by%20state&journal=CA%20Cancer%20J%20Clin&doi=10.3322%2Fcaac.21412&volume=67&issue=6&pages=439-448&publication_year=2017&author=DeSantis%2CCE&author=Ma%2CJ&author=Goding%20Sauer%2CA&author=Newman%2CLA&author=Jemal%2CA
• http://scholar.google.com/scholar_lookup?&title=Survival%20of%20metastatic%20breast%20carcinoma%20patients%20over%20a%2020-year%20period%3A%20a%20retrospective%20analysis%20based%20on%20individual%20patient%20data%20from%20six%20consecutive%20studies&journal=Cancer&doi=10.1002%2Fcncr.21359&volume=104&issue=8&pages=1742-1750&publication_year=2005&author=Gennari%2CA&author=Conte%2CP&author=Rosso%2CR&author=Orlandini%2CC&author=Bruzzi%2CP's revenue stream
• What's http://scholar.google.com/scholar_lookup?&title=Clinically%20used%20breast%20cancer%20markers%20such%20as%20estrogen%20receptor%2C%20progesterone%20receptor%2C%20and%20human%20epidermal%20growth%20factor%20receptor%202%20are%20unstable%20throughout%20tumor%20progression&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2011.37.2482&volume=30&issue=21&pages=2601-2608&publication_year=2012&author=Lindstr%C3%B6m%2CLS&author=Karlsson%2CE&author=Wilking%2CUM&author=Johansson%2CU&author=Hartman%2CJ&author=Lidbrink%2CEK&author=Hatschek%2CT&author=Skoog%2CL&author=Bergh%2CJ's gross income?
• How much money does http://scholar.google.com/scholar_lookup?&title=Endocrine%20therapy%20for%20hormone%20receptor%20positive%20metastatic%20breast%20cancer%3A%20American%20Society%20of%20Clinical%20Oncology%20Guideline%20summary&journal=J%20Oncol%20Pract&doi=10.1200%2FJOP.2016.012914&volume=12&issue=6&pages=583-587&publication_year=2016&author=Rugo%2CHS&author=Rumble%2CRB&author=Burstein%2CHJ make?
• How much does https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:CAS:528:DC%2BC3MXivVWhtLo%3D rake in every month?
• Check the income stats for http://scholar.google.com/scholar_lookup?&title=Mechanisms%20of%20endocrine%20resistance%20in%20breast%20cancer&journal=Annu%20Rev%20Med&doi=10.1146%2Fannurev-med-070909-182917&volume=62&pages=233-247&publication_year=2011&author=Osborne%2CCK&author=Schiff%2CR
• How much does https://link.springer.com/doi/10.1186/s13058-015-0661-5 pull in?
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Targeting%20the%20cyclin-dependent%20kinases%20%28CDK%294%2F6%20in%20estrogen%20receptor-positive%20breast%20cancers&journal=Breast%20Cancer%20Res&doi=10.1186%2Fs13058-015-0661-5&volume=18&issue=1&publication_year=2016&author=Finn%2CRS&author=Aleshin%2CA&author=Slamon%2CDJ?
• How much does https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:CAS:528:DC%2BC2MXht1yhsb8%3D earn?
• http://scholar.google.com/scholar_lookup?&title=The%20cyclin-dependent%20kinase%204%2F6%20inhibitor%20palbociclib%20in%20combination%20with%20letrozole%20versus%20letrozole%20alone%20as%20first%20line%20treatment%20of%20oestrogen%20receptor-positive%2C%20HER2-negative%2C%20advanced%20breast%20cancer%20%28PALOMA-1%2FTRIO-18%29%3A%20a%20randomised%20phase%202%20study&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2814%2971159-3&volume=16&issue=1&pages=25-35&publication_year=2015&author=Finn%2CRS&author=Crown%2CJP&author=Lang%2CI&author=Boer%2CK&author=Bondarenko%2CIM&author=Kulyk%2CSO&author=Ettl%2CJ&author=Patel%2CR&author=Pinter%2CT&author=Schmidt%2CM's financial summary
• What's the monthly income of https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:CAS:528:DC%2BC28XhvF2ksrfM?
• How profitable is http://scholar.google.com/scholar_lookup?&title=Palbociclib%20and%20letrozole%20in%20advanced%20breast%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1607303&volume=375&issue=20&pages=1925-1936&publication_year=2016&author=Finn%2CRS&author=Martin%2CM&author=Rugo%2CHS&author=Jones%2CS&author=Im%2CS-A&author=Gelmon%2CK&author=Harbeck%2CN&author=Lipatov%2CON&author=Walshe%2CJM&author=Moulder%2CS&author=Gauthier%2CE&author=Lu%2CDR&author=Randolph%2CS&author=Di%C3%A9ras%2CV&author=Slamon%2CDJ?
• https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:CAS:528:DC%2BC28XhvF2ksrbO's revenue stream
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Ribociclib%20as%20first-line%20therapy%20for%20HR-positive%2C%20advanced%20breast%20cancer&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1609709&volume=375&issue=18&pages=1738-1748&publication_year=2016&author=Hortobagyi%2CGN&author=Stemmer%2CSM&author=Burris%2CHA&author=Yap%2CYS&author=Sonke%2CGS&author=Paluch-Shimon%2CS&author=Campone%2CM&author=Blackwell%2CKL&author=Andre%2CF&author=Winer%2CEP&author=Janni%2CW?
• https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:CAS:528:DC%2BC28Xjs1yhsLo%3D's total income per month
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Fulvestrant%20plus%20palbociclib%20versus%20fulvestrant%20plus%20placebo%20for%20treatment%20of%20hormone-receptor-positive%2C%20HER2-negative%20metastatic%20breast%20cancer%20that%20progressed%20on%20previous%20endocrine%20therapy%20%28PALOMA-3%29%3A%20final%20analysis%20of%20the%20multicentre%2C%20double-blind%2C%20phase%203%20randomised%20controlled%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2815%2900613-0&volume=17&issue=4&pages=425-439&publication_year=2016&author=Cristofanilli%2CM&author=Turner%2CNC&author=Bondarenko%2CI&author=Ro%2CJ&author=Im%2CS-A&author=Masuda%2CN&author=Colleoni%2CM&author=DeMichele%2CA&author=Loi%2CS&author=Verma%2CS&author=Iwata%2CS&author=Harbeck%2CN&author=Zhang%2CK?
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=MONARCH%202%3A%20abemaciclib%20in%20combination%20with%20fulvestrant%20in%20women%20with%20HR%2B%2FHER2%20advanced%20breast%20cancer%20who%20had%20progressed%20while%20receiving%20endocrine%20therapy&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2017.73.7585&volume=35&issue=25&pages=2875-2884&publication_year=2017&author=Sledge%2CGW&author=Toi%2CM&author=Neven%2CP&author=Sohn%2CJ&author=Inoue%2CK&author=Pivot%2CX&author=Burdaeva%2CO&author=Okera%2CM&author=Masuda%2CN&author=Kaufman%2CPA&author=Koh%2CH&author=Grischke%2CEM&author=Frenzel%2CM&author=Lin%2CY&author=Barriga%2CS&author=Smith%2CIC&author=Bourayou%2CN&author=Llombart-Cussac%2CA each month?
• What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=MONARCH%203%3A%20abemaciclib%20as%20initial%20therapy%20for%20advanced%20breast%20cancer&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2017.75.6155&volume=35&issue=32&pages=3638-3646&publication_year=2017&author=Goetz%2CMP&author=Toi%2CM&author=Campone%2CM&author=Sohn%2CJ&author=Paluch-Shimon%2CS&author=Huober%2CJ&author=Park%2CIH&author=Tr%C3%A9dan%2CO&author=Chen%2CSC&author=Manso%2CL&author=Freedman%2COC&author=Garnica%20Jaliffe%2CG&author=Forrester%2CT&author=Frenzel%2CM&author=Barriga%2CS&author=Smith%2CIC&author=Bourayou%2CN&author=Leo%2CA?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29804902 pull in monthly?
• Profit of http://scholar.google.com/scholar_lookup?&title=Ribociclib%20plus%20endocrine%20therapy%20for%20premenopausal%20women%20with%20hormone-receptor-positive%2C%20advanced%20breast%20cancer%20%28MONALEESA-7%29%3A%20a%20randomised%20phase%203%20trial&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2818%2930292-4&publication_year=2018&author=Tripathy%2CD&author=Im%2CSA&author=Colleoni%2CM&author=Franke%2CF&author=Bardia%2CA&author=Harbeck%2CN&author=Hurvitz%2CSA&author=Chow%2CL&author=Sohn%2CJ&author=Lee%2CKS&author=Campos-Gomez%2CS&author=Villanueva%20Vazquez%2CR&author=Jung%2CKH&author=Babu%2CKG&author=Wheatley-Price%2CP&author=Laurentiis%2CM&author=Im%2CYH&author=Kuemmel%2CS&author=El-Saghir%2CN&author=Liu%2CMC&author=Carlson%2CG&author=Hughes%2CG&author=Diaz-Padilla%2CI&author=Germa%2CC&author=Hirawat%2CS&author=Lu%2CYS
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29860922 earning monthly?
• What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Phase%20III%20randomized%20study%20of%20ribociclib%20and%20fulvestrant%20in%20hormone%20receptor-positive%2C%20human%20epidermal%20growth%20factor%20receptor%202-negative%20advanced%20breast%20cancer%3A%20MONALEESA-3&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2018.78.9909&publication_year=2018&author=Slamon%2CDJ&author=Neven%2CP&author=Chia%2CS&author=Fasching%2CPA&author=Laurentiis%2CM&author=Im%2CSA&author=Petrakova%2CK&author=Bianchi%2CGV&author=Esteva%2CFJ&author=Mart%C3%ADn%2CM&author=Nusch%2CA&author=Sonke%2CGS&author=Cruz-Merino%2CL&author=Beck%2CJT&author=Pivot%2CX&author=Vidam%2CG&author=Wang%2CY&author=Rodriguez%20Lorenc%2CK&author=Miller%2CM&author=Taran%2CT&author=Jerusalem%2CG?
• How much profit is http://scholar.google.com/scholar_lookup?&title=Meta-analysis&publication_year=2008&author=Greenland%2CS&author=O%E2%80%99Rourke%2CK making per month?
• Get to know https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:STN:280:DyaG1M%2FosVOhtQ%3D%3D's earnings
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=13655060 generate?
• http://scholar.google.com/scholar_lookup?&title=Statistical%20aspects%20of%20the%20analysis%20of%20data%20from%20retrospective%20studies%20of%20disease&journal=J%20Natl%20Cancer%20Inst&volume=22&issue=4&pages=719-748&publication_year=1959&author=Mantel%2CN&author=Haenszel%2CW income
• What is the earnings of http://scholar.google.com/scholar_lookup?&title=Quantifying%20heterogeneity%20in%20a%20meta-analysis&journal=Stat%20Med&doi=10.1002%2Fsim.1186&volume=21&issue=11&pages=1539-1558&publication_year=2002&author=Higgins%2CJP&author=Thompson%2CSG?
• See how much http://scholar.google.com/scholar_lookup?&title=Statistical%20heterogeneity%20in%20systematic%20reviews%20of%20clinical%20trials%3A%20a%20critical%20appraisal%20of%20guidelines%20and%20practice&journal=J%20Health%20Serv%20Res%20Policy&doi=10.1258%2F1355819021927674&volume=7&issue=1&pages=51-61&publication_year=2002&author=Higgins%2CJ&author=Thompson%2CS&author=Deeks%2CJ&author=Altman%2CD makes per month
• Check the income stats for https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:CAS:528:DC%2BC2sXhsVOrsbrN
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Palbociclib%20in%20hormone%20receptor%20positive%20advanced%20breast%20cancer%3A%20a%20cost-utility%20analysis&journal=Eur%20J%20Cancer&doi=10.1016%2Fj.ejca.2017.08.018&volume=85&pages=146-154&publication_year=2017&author=Raphael%2CJ&author=Helou%2CJ&author=Pritchard%2CKI&author=Naimark%2CDM
• What are the earnings of http://scholar.google.com/scholar_lookup?&title=PALOMA-3%3A%20phase%20III%20trial%20of%20fulvestrant%20with%20or%20without%20palbociclib%20in%20premenopausal%20and%20postmenopausal%20women%20with%20hormone%20receptor-positive%2C%20human%20epidermal%20growth%20factor%20receptor%202-negative%20metastatic%20breast%20cancer%20that%20progressed%20on%20prior%20endocrine%20therapy-safety%20and%20efficacy%20in%20Asian%20patients&journal=J%20Glob%20Oncol&doi=10.1200%2FJGO.2016.008318&volume=3&issue=4&pages=289-303&publication_year=2017&author=Iwata%2CH&author=Im%2CSA&author=Masuda%2CN&author=Im%2CYH&author=Inoue%2CK&author=Rai%2CY&author=Nakamura%2CR&author=Kim%2CJH&author=Hoffman%2CJT&author=Zhang%2CK&author=Giorgetti%2CC&author=Iyer%2CS&author=Schnell%2CPT&author=Bartlett%2CCH&author=Ro%2CJ?
• Profit of https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:CAS:528:DC%2BC2sXhvFaqs7nM
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Palbociclib%20combined%20with%20fulvestrant%20in%20premenopausal%20women%20with%20advanced%20breast%20cancer%20and%20prior%20progression%20on%20endocrine%20therapy%3A%20PALOMA-3%20results&journal=Oncologist&doi=10.1634%2Ftheoncologist.2017-0072&volume=22&issue=9&pages=1028-1038&publication_year=2017&author=Loibl%2CS&author=Turner%2CNC&author=Ro%2CJ&author=Cristofanilli%2CM&author=Iwata%2CH&author=Im%2CSA&author=Masuda%2CN&author=Loi%2CS&author=Andr%C3%A9%2CF&author=Harbeck%2CN&author=Verma%2CS&author=Folkerd%2CE&author=Puyana%20Theall%2CK&author=Hoffman%2CJ&author=Zhang%2CK&author=Bartlett%2CCH&author=Dowsett%2CM bring in?
• What are the earnings of https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:CAS:528:DC%2BC1cXhsVKqsbk%3D?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Palbociclib%20in%20combination%20with%20fulvestrant%20in%20women%20with%20hormone%20receptor-positive%2FHER2-negative%20advanced%20metastatic%20breast%20cancer%3A%20detailedsafety%20analysis%20from%20a%20multicenter%2C%20randomized%2C%20placebo-controlled%2C%20phase%20III%20study%20%28PALOMA-3%29&journal=Oncologist&doi=10.1634%2Ftheoncologist.2016-0097&volume=21&issue=10&pages=1165-1175&publication_year=2016&author=Verma%2CS&author=Bartlett%2CCH&author=Schnell%2CP&author=DeMichele%2CAM&author=Loi%2CS&author=Ro%2CJ&author=Colleoni%2CM&author=Iwata%2CH&author=Harbeck%2CN&author=Cristofanilli%2CM&author=Zhang%2CK&author=Thiele%2CA&author=Turner%2CNC&author=Rugo%2CHS?
• What's https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:STN:280:DC%2BC28flt1yrug%3D%3D's gross income?
• How much income does http://scholar.google.com/scholar_lookup?&title=Quality%20of%20life%20with%20palbociclib%20plus%20fulvestrant%20in%20previously%20treated%20hormone%20receptor-positive%2C%20HER2-negative%20metastatic%20breast%20cancer%3A%20patient-reported%20outcomes%20from%20the%20PALOMA-3%20trial&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdw139&volume=27&issue=6&pages=1047-1054&publication_year=2016&author=Harbeck%2CN&author=Iyer%2CS&author=Turner%2CN&author=Cristofanilli%2CM&author=Ro%2CJ&author=Andr%C3%A9%2CF&author=Loi%2CS&author=Verma%2CS&author=Iwata%2CH&author=Bhattacharyya%2CH&author=Puyana%20Theall%2CK&author=Bartlett%2CCH&author=Loibl%2CS have?
• Get to know what's the income of https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:CAS:528:DC%2BC28XosFChsr8%3D
• What's http://scholar.google.com/scholar_lookup?&title=Management%20of%20patients%20with%20hormone%20receptor-positive%20breast%20cancer%20with%20visceral%20disease%3A%20challenges%20and%20treatment%20options&journal=Cancer%20Manag%20Res&doi=10.2147%2FCMAR.S72592&volume=7&pages=37-46&publication_year=2015&author=Harb%2CWA's gross income?
• What's the income generated by https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:STN:280:DC%2BC28vislGhtw%3D%3D each month?
• How much does http://scholar.google.com/scholar_lookup?&title=In%20real%20life%2C%20one-quarter%20of%20patients%20with%20hormone%20receptor-positive%20metastatic%20breast%20cancer%20receive%20chemotherapy%20as%20initial%20palliative%20therapy%3A%20a%20study%20of%20the%20Southeast%20Netherlands%20Breast%20Cancer%20Consortium&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdv544&volume=27&issue=2&pages=256-262&publication_year=2016&author=Lobbezoo%2CDJ&author=Kampen%2CRJ&author=Voogd%2CAC&author=Dercksen%2CMW&author=Berkmortel%2CF&author=Smilde%2CTJ&author=Wouw%2CAJ&author=Peters%2CFP&author=Riel%2CJM&author=Peters%2CNA&author=Boer%2CM&author=Peer%2CPG&author=Tjan-Heijnen%2CVC pull in?
• How much does https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:STN:280:DC%2BC1cnltVaiuw%3D%3D gross monthly?
• How much revenue does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28177437 bring in?
• Monthly income for http://scholar.google.com/scholar_lookup?&title=3rd%20ESO-ESMO%20International%20Consensus%20Guidelines%20for%20Advanced%20Breast%20Cancer%20%28ABC%203%29&journal=Ann%20Oncol&volume=28&issue=1&pages=16-33&publication_year=2017&author=Cardoso%2CF&author=Costa%2CA&author=Senkus%2CE&author=Aapro%2CM&author=Andr%C3%A9%2CF&author=Barrios%2CCH&author=Bergh%2CJ&author=Bhattacharyya%2CG&author=Biganzoli%2CL&author=Cardoso%2CMJ&author=Carey%2CL&author=Corneliussen-James%2CD&author=Curigliano%2CG&author=Dieras%2CV&author=Saghir%2CN&author=Eniu%2CA&author=Fallowfield%2CL&author=Fenech%2CD&author=Francis%2CP&author=Gelmon%2CK&author=Gennari%2CA&author=Harbeck%2CN&author=Hudis%2CC&author=Kaufman%2CB&author=Krop%2CI&author=Mayer%2CM&author=Meijer%2CH&author=Mertz%2CS&author=Ohno%2CS&author=Pagani%2CO&author=Papadopoulos%2CE&author=Peccatori%2CF&author=Penault-Llorca%2CF&author=Piccart%2CMJ&author=Pierga%2CJY&author=Rugo%2CH&author=Shockney%2CL&author=Sledge%2CG&author=Swain%2CS&author=Thomssen%2CC&author=Tutt%2CA&author=Vorobiof%2CD&author=Xu%2CB&author=Norton%2CL&author=Winer%2CE
• What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Chemotherapy%20alone%20versus%20endocrine%20therapy%20alone%20for%20metastatic%20breast%20cancer&journal=Cochrane%20Database%20Syst%20Rev&volume=2&publication_year=2003&author=Wilcken%2CN&author=Hornbuckle%2CJ&author=Ghersi%2CD?
• How much profit does http://scholar.google.com/scholar_lookup?&title=The%20association%20of%20chemotherapy%20versus%20hormonal%20therapy%20and%20health%20outcomes%20among%20patients%20with%20hormone%20receptor-positive%2C%20HER2-negative%20metastatic%20breast%20cancer%3A%20experience%20from%20the%20patient%20perspective&journal=Expert%20Rev%20Pharm%20Outcomes%20Res&volume=14&issue=6&pages=929-940&publication_year=2014&author=Gupta%2CS&author=Zhang%2CJ&author=Jerusalem%2CG make?
• What's the income of https://link.springer.com/doi/10.1007/s10549-017-4404-4?
• How much does https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:CAS:528:DC%2BC2sXht1eqsbnO earn?
• How much revenue does http://scholar.google.com/scholar_lookup?&title=Systematic%20review%20and%20network%20meta-analysis%20comparing%20palbociclib%20with%20chemotherapy%20agents%20for%20the%20treatment%20of%20postmenopausal%20women%20with%20HR-positive%20and%20HER2-negative%20advanced%2Fmetastatic%20breast%20cancer&journal=Breast%20Cancer%20Res%20Treat&doi=10.1007%2Fs10549-017-4404-4&volume=166&issue=1&pages=167-177&publication_year=2017&author=Wilson%2CFR&author=Varu%2CA&author=Mitra%2CD&author=Cameron%2CC&author=Iyer%2CS generate?
• What's the income generated by https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:CAS:528:DC%2BC2sXhslymt7nF each month?
• How much does http://scholar.google.com/scholar_lookup?&title=Risk%20of%20adverse%20events%20with%20the%20addition%20of%20targeted%20agents%20to%20endocrine%20therapy%20in%20patients%20with%20hormone%20receptor-positive%20metastatic%20breast%20cancer%3A%20a%20systematic%20review%20and%20meta-analysis&journal=Cancer%20Treat%20Rev&doi=10.1016%2Fj.ctrv.2017.09.009&volume=62&pages=123-132&publication_year=2018&author=Martel%2CS&author=Bruzzone%2CM&author=Ceppi%2CM&author=Maurer%2CC&author=Ponde%2CNF&author=Ferreira%2CAR&author=Viglietti%2CG&author=Mastro%2CL&author=Prady%2CC&author=Azambuja%2CE&author=Lambertini%2CM pull in monthly?
• What is the monthly revenue of https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:CAS:528:DC%2BC28XmsFeqsbw%3D?
• How much does http://scholar.google.com/scholar_lookup?&title=Mechanistic%20investigation%20of%20bone%20marrow%20suppression%20associated%20with%20palbociclib%20and%20its%20differentiation%20from%20cytotoxic%20chemotherapies&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-15-1421&volume=22&issue=8&pages=2000-2008&publication_year=2016&author=Hu%2CW&author=Sung%2CT&author=Jessen%2CBA&author=Thibault%2CS&author=Finkelstein%2CMB&author=Khan%2CNK&author=Sacaan%2CAI gross monthly?
• How profitable is https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:STN:280:DC%2BC1MvjsVSqsA%3D%3D?
• Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Impact%20of%20palbociclib%20plus%20letrozole%20on%20patient-reported%20health-related%20quality%20of%20life%3A%20results%20from%20the%20PALOMA-2%20trial&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdy012&volume=29&issue=4&pages=888-894&publication_year=2018&author=Rugo%2CHS&author=Di%C3%A9ras%2CV&author=Gelmon%2CKA&author=Finn%2CRS&author=Slamon%2CDJ&author=Martin%2CM&author=Neven%2CP&author=Shparyk%2CY&author=Mori%2CA&author=Lu%2CDR&author=Bhattacharyya%2CH&author=Bartlett%2CCH&author=Iyer%2CS&author=Johnston%2CS&author=Ettl%2CJ&author=Harbeck%2CN
• How much does http://scholar.google.com/scholar_lookup?&title=Abemaciclib%20for%20pre%2Fperimenopausal%20women%20with%20HR%2B%2C%20HER2-%20advanced%20breast%20cancer&journal=Journal%20of%20Clinical%20Oncology&doi=10.1200%2FJCO.2018.36.15_suppl.1002&volume=36&issue=15_suppl&pages=1002-1002&publication_year=2018&author=Neven%2CPatrick&author=Rugo%2CHope%20S.&author=Tolaney%2CSara%20M.&author=Iwata%2CHiroji&author=Toi%2CMasakazu&author=Goetz%2CMatthew%20P.&author=Kaufman%2CPeter%20A.&author=Barriga%2CSusana&author=Lin%2CYong&author=Sledge%2CGeorge%20W. gross monthly?
• How much does http://scholar.google.com/scholar_lookup?&title=Overall%20survival%20results%20from%20the%20randomized%20phase%20II%20study%20of%20palbociclib%20%28P%29%20in%20combination%20with%20letrozole%20%28L%29%20vs%20letrozole%20alone%20for%20frontline%20treatment%20of%20ER%2B%2FHER2%E2%88%92%20advanced%20breast%20cancer%20%28PALOMA-1%3B%20TRIO-18%29&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2017.35.15_suppl.1001&volume=34&publication_year=2017&author=Finn%2CRS&author=Crown%2CJ&author=Lang%2CI&author=Boer%2CK&author=Bondarenko%2CI&author=Kulyk%2CSO&author=Ettl%2CJ&author=Patel%2CR&author=Pinter%2CT&author=Schmidt%2CM&author=Shparyk%2CYV&author=Thummala%2CA&author=Voytko%2CNL&author=Fowst%2CC&author=Huang%2CX&author=Kim%2CS&author=Slamon%2CDJ earn?
• Find out how much https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:STN:280:DC%2BC1MjovFKjsw%3D%3D earns monthly
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29718092 generate?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Updated%20results%20from%20MONALEESA-2%2C%20a%20phase%20III%20trial%20of%20first-line%20ribociclib%20plus%20letrozole%20versus%20placebo%20plus%20letrozole%20in%20hormone%20receptor-positive%2C%20HER2-negative%20advanced%20breast%20cancer&journal=Ann%20Oncol&volume=29&pages=1541-1547&publication_year=2018&author=Hortobagyi%2CGN&author=Stemmer%2CSM&author=Burris%2CHA&author=Yap%2CYS&author=Sonke%2CGS&author=Paluch-Shimon%2CS&author=Campone%2CM&author=Petrakova%2CK&author=Blackwell%2CKL&author=Winer%2CEP&author=Janni%2CW&author=Verma%2CS&author=Conte%2CP&author=Arteaga%2CCL&author=Cameron%2CDA&author=Mondal%2CS&author=Su%2CF&author=Miller%2CM&author=Elmeliegy%2CM&author=Germa%2CC&author=O%E2%80%99Shaughnessy%2CJ have monthly?
• Income figures for https://link.springer.com/article/10.1007/s10549-018-4901-0/articles/cas-redirect/1:STN:280:DC%2BC2szosVahsA%3D%3D
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=A%20standardised%2C%20generic%2C%20validated%20approach%20to%20stratify%20the%20magnitude%20of%20clinical%20benefit%20that%20can%20be%20anticipated%20from%20anti-cancer%20therapies%3Athe%20European%20Society%20for%20Medical%20Oncology%20Magnitude%20of%20Clinical%20Benefit%20Scale%28ESMO-MCBS%29&journal=Ann%20Oncol&doi=10.1093%2Fannonc%2Fmdx521&volume=28&issue=11&pages=2901-2905&publication_year=2017&author=Cherny%2CNI&author=Sullivan%2CR&author=Dafni%2CU&author=Kerst%2CJM&author=Sobrero%2CA&author=Zielinski%2CC&author=Vries%2CEGE&author=Piccart%2CMJ?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Detecting%20an%20overall%20survival%20benefit%20that%20is%20derived%20from%20progression-free%20survival&journal=J%20Natl%20Cancer%20Inst&doi=10.1093%2Fjnci%2Fdjp369&volume=101&issue=23&pages=1642-1649&publication_year=2009&author=Broglio%2CKR&author=Berry%2CDA
• How much does https://citation-needed.springer.com/v2/references/10.1007/s10549-018-4901-0?format=refman&flavour=references generate monthly?
• What are the total earnings of https://link.springer.com/article/10.1007/s10549-018-4901-0/search?sortBy=newestFirst&dc.creator=Carlo%20Messina?
• How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Carlo%20Messina generate?
• What's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Carlo%20Messina%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• What are the total earnings of https://link.springer.com/article/10.1007/s10549-018-4901-0/search?sortBy=newestFirst&dc.creator=Carlo%20Cattrini?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Carlo%20Cattrini earn?
• Explore the financials of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Carlo%20Cattrini%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the financial intake of https://link.springer.com/article/10.1007/s10549-018-4901-0/search?sortBy=newestFirst&dc.creator=Giulia%20Buzzatti?
• Revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Giulia%20Buzzatti
• What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Giulia%20Buzzatti%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
• Discover the revenue of https://link.springer.com/article/10.1007/s10549-018-4901-0/search?sortBy=newestFirst&dc.creator=Luigi%20Cerbone
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Luigi%20Cerbone pull in monthly?
• How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Luigi%20Cerbone%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in?
• How much income does https://link.springer.com/article/10.1007/s10549-018-4901-0/search?sortBy=newestFirst&dc.creator=Elisa%20Zanardi have?
• What's https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Elisa%20Zanardi's gross income?
• How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Elisa%20Zanardi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
• What's the financial outcome of https://link.springer.com/article/10.1007/s10549-018-4901-0/search?sortBy=newestFirst&dc.creator=Marco%20Messina?
• How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Marco%20Messina generate?
• Get to know what's the income of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Marco%20Messina%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• How much profit does https://link.springer.com/article/10.1007/s10549-018-4901-0/search?sortBy=newestFirst&dc.creator=Francesco%20Boccardo generate?
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Francesco%20Boccardo make?
• How much cash flow does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Francesco%20Boccardo%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have monthly?
• How much income does https://link.springer.com/article/10.1007/s10549-018-4901-0/mailto:[email protected] have?
• Earnings of https://s100.copyright.com/AppDispatchServlet?title=CDK4%2F6%20inhibitors%20in%20advanced%20hormone%20receptor-positive%2FHER2-negative%20breast%20cancer%3A%20a%20systematic%20review%20and%20meta-analysis%20of%20randomized%20trials&author=Carlo%20Messina%20et%20al&contentID=10.1007%2Fs10549-018-4901-0©right=Springer%20Science%2BBusiness%20Media%2C%20LLC%2C%20part%20of%20Springer%20Nature&publication=0167-6806&publicationDate=2018-07-27&publisherName=SpringerNature&orderBeanReset=true
• Earnings of https://crossmark.crossref.org/dialog/?doi=10.1007/s10549-018-4901-0
• Get to know what's the income of https://citation-needed.springer.com/v2/references/10.1007/s10549-018-4901-0?format=refman&flavour=citation
• How much profit does https://link.springer.com/article/10.1007/s10549-018-4901-0/search?query=Abemaciclib&facet-discipline="Medicine%20%26%20Public%20Health" generate?
• Get to know what's the income of https://link.springer.com/article/10.1007/s10549-018-4901-0/search?query=Ribociclib&facet-discipline="Medicine%20%26%20Public%20Health"
• How much does https://link.springer.com/article/10.1007/s10549-018-4901-0/search?query=Palbociclib&facet-discipline="Medicine%20%26%20Public%20Health" generate monthly?
• What's the total monthly financial gain of https://link.springer.com/article/10.1007/s10549-018-4901-0/search?query=Hormonal%20therapy&facet-discipline="Medicine%20%26%20Public%20Health"?
• Discover the revenue of https://link.springer.com/article/10.1007/s10549-018-4901-0/search?query=Breast%20cancer&facet-discipline="Medicine%20%26%20Public%20Health"
• How much does https://link.springer.com/article/10.1007/s10549-018-4901-0/search?query=Meta-analysis&facet-discipline="Medicine%20%26%20Public%20Health" gross monthly?
• How profitable is https://link.springer.com/article/10.1007/s10549-018-4901-0/researchers/86911930SN?
• What's the income of https://link.springer.com/journals/a/1?
• How much income does https://link.springer.com/books/a/1 have?
• Get to know https://link.springer.com/journals's earnings
• What's https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral's gross income?
• Discover the revenue of https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research
• How much profit does https://www.springernature.com/gp/products generate?
• Explore the financials of https://www.springernature.com/gp/librarians
• How profitable is https://www.springernature.com/gp/societies?
• How much money does https://www.springernature.com/gp/partners make?
• What are the earnings of https://www.springer.com/?
• What's the income generated by https://www.nature.com/ each month?
• How much money does https://www.biomedcentral.com/ generate?
• How much does https://www.palgrave.com/ pull in?
• What's the financial gain of https://www.apress.com/?
• How much profit does https://link.springer.com/brands/discover make?
• How much money does https://www.springernature.com/gp/legal/ccpa make?
• How much money does https://www.springernature.com/gp/info/accessibility generate?
• How much does https://link.springer.com/termsandconditions bring in each month?
• How much does https://support.springernature.com/en/support/home pull in?
• How much does https://link.springer.com/legal-notice generate monthly?
• What is the monthly revenue of https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations?
• Find out how much https://www.springernature.com/ earns monthly

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js

Emails and Hosting {✉️}

Mail Servers:

• mx.zoho.eu
• mx2.zoho.eu
• mx3.zoho.eu

Name Servers:

• josh.ns.cloudflare.com
• zita.ns.cloudflare.com

CDN Services {📦}

• Crossref